Hey PJ, Twells RC, Phillips MS, Brown SD, Kawaguchi Y, Cox R, Dugan V, Hammond H, Metzker ML, Todd JA, Hess JF (Aug 1998). "Cloning of a novel member of the low-density lipoprotein receptor family". Gene. 216 (1): 103–11. doi:10.1016/S0378-1119(98)00311-4. PMID9714764.
Chen D, Lathrop W, Dong Y (Feb 1999). "Molecular cloning of mouse Lrp7(Lr3) cDNA and chromosomal mapping of orthologous genes in mouse and human". Genomics. 55 (3): 314–21. doi:10.1006/geno.1998.5688. PMID10049586.
Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG (Jun 2011). "Lrp5 functions in bone to regulate bone mass". Nature Medicine. 17 (6): 684–91. doi:10.1038/nm.2388. PMC3113461. PMID21602802.
Zhang W, Drake MT (Mar 2012). "Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis". Current Osteoporosis Reports. 10 (1): 93–100. doi:10.1007/s11914-011-0086-8. PMID22210558. S2CID23718294.
Baron R, Kneissel M (Feb 2013). "WNT signaling in bone homeostasis and disease: from human mutations to treatments". Nature Medicine. 19 (2): 179–92. doi:10.1038/nm.3074. PMID23389618. S2CID19968640.
Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F (Jun 2003). "High bone mass in mice expressing a mutant LRP5 gene". Journal of Bone and Mineral Research. 18 (6): 960–74. doi:10.1359/jbmr.2003.18.6.960. PMID12817748. S2CID36863658.
Ahn J, Lee H, Kim S, Ha T (Jun 2010). "Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling". American Journal of Physiology. Cell Physiology. 298 (6): C1510–6. doi:10.1152/ajpcell.00369.2009. PMID20357182. S2CID25514556.
Hey PJ, Twells RC, Phillips MS, Brown SD, Kawaguchi Y, Cox R, Dugan V, Hammond H, Metzker ML, Todd JA, Hess JF (Aug 1998). "Cloning of a novel member of the low-density lipoprotein receptor family". Gene. 216 (1): 103–11. doi:10.1016/S0378-1119(98)00311-4. PMID9714764.
Chen D, Lathrop W, Dong Y (Feb 1999). "Molecular cloning of mouse Lrp7(Lr3) cDNA and chromosomal mapping of orthologous genes in mouse and human". Genomics. 55 (3): 314–21. doi:10.1006/geno.1998.5688. PMID10049586.
Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG (Jun 2011). "Lrp5 functions in bone to regulate bone mass". Nature Medicine. 17 (6): 684–91. doi:10.1038/nm.2388. PMC3113461. PMID21602802.
Zhang W, Drake MT (Mar 2012). "Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis". Current Osteoporosis Reports. 10 (1): 93–100. doi:10.1007/s11914-011-0086-8. PMID22210558. S2CID23718294.
Baron R, Kneissel M (Feb 2013). "WNT signaling in bone homeostasis and disease: from human mutations to treatments". Nature Medicine. 19 (2): 179–92. doi:10.1038/nm.3074. PMID23389618. S2CID19968640.
Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F (Jun 2003). "High bone mass in mice expressing a mutant LRP5 gene". Journal of Bone and Mineral Research. 18 (6): 960–74. doi:10.1359/jbmr.2003.18.6.960. PMID12817748. S2CID36863658.
Ahn J, Lee H, Kim S, Ha T (Jun 2010). "Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling". American Journal of Physiology. Cell Physiology. 298 (6): C1510–6. doi:10.1152/ajpcell.00369.2009. PMID20357182. S2CID25514556.
Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG (Jun 2011). "Lrp5 functions in bone to regulate bone mass". Nature Medicine. 17 (6): 684–91. doi:10.1038/nm.2388. PMC3113461. PMID21602802.
Zhang W, Drake MT (Mar 2012). "Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis". Current Osteoporosis Reports. 10 (1): 93–100. doi:10.1007/s11914-011-0086-8. PMID22210558. S2CID23718294.
Baron R, Kneissel M (Feb 2013). "WNT signaling in bone homeostasis and disease: from human mutations to treatments". Nature Medicine. 19 (2): 179–92. doi:10.1038/nm.3074. PMID23389618. S2CID19968640.
Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F (Jun 2003). "High bone mass in mice expressing a mutant LRP5 gene". Journal of Bone and Mineral Research. 18 (6): 960–74. doi:10.1359/jbmr.2003.18.6.960. PMID12817748. S2CID36863658.
Ahn J, Lee H, Kim S, Ha T (Jun 2010). "Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling". American Journal of Physiology. Cell Physiology. 298 (6): C1510–6. doi:10.1152/ajpcell.00369.2009. PMID20357182. S2CID25514556.